4DCT radiotherapy for NSCLC: a review of planning methods by Hutchinson, Adam & Bridge, Pete
Journal of
Radiotherapy
in Practice
Journal of Radiotherapy in Practice (2014)
Page 1 of 10 & Cambridge University Press 2014
doi:10.1017/S1460396914000041
Literature Review
4DCT radiotherapy for NSCLC: a review of planning methods
A. Hutchinson1, P. Bridge2
1Radiation Oncology Mater Centre, South Brisbane, 2School of Clinical Sciences, Queensland University of
Technology, Brisbane, Australia
(Received 14th August 2013; accepted 28th November 2013)
Abstract
Purpose: To establish whether the use of a passive or active technique of planning target volume (PTV)
definition and treatment methods for non-small cell lung cancer (NSCLC) deliver the most effective results.
This literature review assesses the advantages and disadvantages in recent studies of each, while assessing
the validity of the two approaches for planning and treatment.
Methods: A systematic review of literature focusing on the planning and treatment of radiation therapy to
NSCLC tumours. Different approaches which have been published in recent articles are subjected to critical
appraisal in order to determine their relative efficacy.
Results: Free-breathing (FB) is the optimal method to perform planning scans for patients and departments, as
it involves no significant increase in cost, workload or education. Maximum intensity projection (MIP) is the
fastest form of delineation, however it is noted to be less accurate than the ten-phase overlap approach for
computed tomography (CT). Although gating has proven to reduce margins and facilitate sparing of organs at
risk, treatment times can be longer and planning time can be as much as 15 times higher for intensity
modulated radiation therapy (IMRT). This raises issues with patient comfort and stabilisation, impacting on the
chance of geometric miss. Stereotactic treatments can take up to 3 hours to treat, along with increases in
planning and treatment, as well as the additional hardware, software and training required.
Conclusion: Four-dimensional computed tomography (4DCT) is superior to 3DCT, with the passive FB
approach for PTV delineation and treatment optimal. Departments should use a combination of MIP
with visual confirmation ensuring coverage for stage 1 disease. Stages 2–3 should be delineated using
ten-phases overlaid. Stereotactic and gated treatments for early stage disease should be used accordingly;
FB-IMRT is optimal for latter stage disease.
Keywords: computed tomography (CT); delineation; four-dimensional computed tomography (4DCT); free-
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INTRODUCTION
Lung cancer is responsible for ,7,600 deaths
annually and over 10,000 diagnoses per year in
Australia.1 Non-small cell lung cancer (NSCLC)
is responsible for up to 85% of lung cancers,
with a 5 year survival rate of ,10–20% using
3D conformal radiation therapy (3DCRT).
Treatment options commonly available to
patients include surgery, chemotherapy and
radiation therapy. However, due to the age and
co-morbidities of the majority of patients, surgery
is commonly not performed. Chemotherapy has
also shown an increase in toxicities with little
improvement to local control.2 However, tech-
nologies such as intensity modulated radiation
therapy (IMRT), stereotactic body radiation
therapy (SBRT) and four-dimensional computed
tomography (4DCT) are showing promise in
improving these rates; as high as 47% for 5-year
survival.3
There are several methods commonly used
for delineation of target volumes for NSCLC
patients. For IMRT, SBRTand gated treatments
the need for accurate delineation is paramount.
The free-breathing (FB) 4DCT scans can be
viewed individually, forming ten separate scans
that are delineated separately. Breath-hold
techniques can be used to form datasets of
end-inspiration and end-expiration to compare
the extent of motion at either end of the
respiratory cycle. Maximum intensity projection
(MIP) uses the maximum voxel intensities across
all phases of the patient’s breathing cycle to form
a single scan with a volume accounting for the
entirety of motion.2 Average intensity (AI)
performs a similar method whereby it allocates
the AI voxels to form a volume.2,4 Each of these
methods has advantages and disadvantages
which will be reviewed in this paper.
The accuracy of delineation is increased when
using multiple stages of the breathing cycle:
from inhalation to mid ventilation or from mid
ventilation to exhalation. This accounts for
differences throughout the breathing cycle and
also illustrates the overall displacement in three
dimensions.5 Methods of 4DCTessentially form
an oversampled 3DCT scan, which can be
separated into phases of the breathing cycle to
determine time-specific target positions. The
planning scan is performed with the patient in
the treatment position, under natural FB conditions
in the majority of cases.6
Planning target volume (PTV) delineation for
NSCLC patients can be performed in two
definitive ways using 4D technology. The first is
to use computed tomography (CT) data to
depict the extent of motion of the target and
incorporate this motion as part of the PTV
(internal target volume (ITV)), increasing the
accuracy of treating the structure, thus tumour
control probability (TCP), but increasing normal
tissue dose and normal tissue complication
probability (NTCP). This is deemed a ‘passive’
approach, as the treatment of the patient is
delivered under the same FB circumstances as a
3DCRT plan. The alternative is to use tracking
systems and/or gating methods to acquire CT
data and treat a reduced volume while increasing
the likelihood of treating the target during a
specific respiratory stage. This is an ‘active’
approach and has the potential to escalate dose
to the target and minimise normal tissue dose,
increasing TCP. Active methods rely on sig-
nificant stabilisation and imaging equipment to
negate geometric miss.7,8
Unfortunately, conventional CT images of
lung tumours generate artefacts and blurring
of the internal anatomy due to the stacking of
images with no perception of time.9 Helical CT
commonly used for planning purposes, forms
only a snapshot of the tumour position during
differing phases of the respiratory cycle. Artefacts
and degradation of the volume is common in
3D scans, increasing geometric uncertainties. These
are commonly accounted for by the internal (IM)
and set up (SM) margins within radiotherapy
treatments. The IM consists of the displacement the
target experiences throughout the entire breathing
cycle, forming the ITV.7 Although the ITV
increases geometric accuracy, the increase in normal
tissue and critical structure dose significantly reduces
patient quality of life.6
An innovative method designed to account
for respiratory motion is 4DCT. By increasing
the scan time and decreasing pitch (movement
rate of the CT couch) the breathing cycle and
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subsequent position of the target volume can be
viewed across ten discrete phases.8 This provides
temporal and spatial information critical to
reducing geometric uncertainties for accurate
delineation of target volumes across the breath-
ing cycle.4,10 4DCT has created opportunities to
treat patients with SBRT, IMRT and gating
techniques.8,11
There are multiple technologies available to
monitor breathing patterns of patients, including
active breathing control (ABC) and real-time
position management (RPM).12 The latter track-
ing system utilises external markers with infra-red
technology to monitor their displacement. Due to
the complications and co-morbidities exhibited by
many lung patients, external markers are more
suitable and are less invasive than internal markers,
which some systems can use.8
Limitations with conventional treatment
occur due to the sensitivity of organs such as
lungs, whereby late toxicities from extensive
low-dose to large volumes of organ reduce the
likelihood of escalating dose. IMRT is designed
to treat complex volumes, avoiding organs at
risk (OAR) and thus allow for dose escalation to
target volumes. Unlike conventional planning,
the V20 lung dose can be within tolerance,
however the V5 or V20 volumes can be much
larger (as high as 50%) compared with the lower
doses achieved in 3DCRT. Additionally, two
other factors are crucial to the use of IMRT as
an accurate alternative: tumour motion and
target delineation. Due to the complexity of
IMRTand the use of dynamic MLCs, the effects
of target-miss are emphasised, therefore a
method to account for these is required.13
Recent literature demonstrates that FB during
IMRT treatments proves insignificant to the dose
distribution changes between planning system and
treatment. This strengthens the validity for FB
4DCT techniques to be used in the planning of
NSCLC patients, as the dosimetric variation
between planning and treatment is not affected
by the respiratory cycle, while the 4DCT increases
accuracy of delineation.14
SBRT techniques allow for a higher dose per
fraction compared with 3DCRT or IMRT, by
using accurate imaging practices and superior
stabilisation equipment. A hyper-fractionated
dose of 60Gy in three fractions is used, giving a
biological equivalent dose of 100Gy, significantly
improving local control. SBRT is limited by the
shortfalls of target volume outlining, highlighting
the need for faster and more reliable delineation
methods. It is unlikely SBRT can be used for
latter-stage disease due to requirements of smaller
treatment volumes.11 30% of NSCLC patients are
stage 4 at the time of diagnosis, indicating the need
to adopt optimal planning and treatment regimes
for early stage disease.13
This systematic literature review aims to
compare the wide variety of planning methods
in the current evidence base in order to
determine the optimal technique for 4DCT
planning of NSCLC.
METHODS
The purpose of this review was to establish the
optimal technique for PTV definition and treat-
ment of NSCLC. Literature reviewed was located
predominantly via ScienceDirect and EBSCOHost
databases such as PubMed and Medline. Papers
were located that satisfied a range of criteria: related
to a diagnosis of NSCLC, published within 10 years
and focused on treatment planning methods. Papers
with poor reliability were rejected.
DISCUSSION
Delineation methods
The delineation of target volumes for NSCLC
patients is problematic due to the extent of
motion experienced throughout the breathing
cycle. Various methods can account for this,
such as MIP, AI end-of-expiration (EOE), end-
of-inspiration (EOI) and ten-phase overlap
approaches.2 The ten-phase overlap approach
delineates the target in each phase of the breathing
cycle individually. This is clinically unsuitable
as it can take ,2?5 hours to perform.10 Table 1
summarises the relative advantages and disadvan-
tages of the different delineation methods.
Bradley et al.9 noted that for stage 1 NSCLC,
MIP was more reliable than either AI or the
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common 3D helical scan delineation types.
However, it was noted that the accuracy of
dosimetric calculations on MIP datasets is
inferior to that of AI, as electron densities
cannot be recorded. As such, MIP can be used
to identify target position, whereas AI is
required to represent the dosimetric outcomes
of the patient’s treatment accurately.
This was supported further by Muirhead
et al.,10 who found that MIPs performed on
stage 1 patients were similar to that of the
common ten-phase overlap approach, and thus
should be used to decrease planning time.
However, the study also showed that stage 2–3
disease resulted in MIP datasets to underestimate
the target volumes. In this case MIP cannot
distinguish boundaries between tissues with
similar or higher Hounsfield Units, and there-
fore erroneously rejects these voxels.
Reitz et al.2 contradicted both these studies,
when reviewing IMRT planning of NSCLC
patients in all four stages of disease. The authors
concluded that MIP was superior to that of AI as it
delineated smaller margins. However, the study
consisted of only five patients, three of whom were
stage 1. Larger scale study findings would be
required to refute the other studies. Muirhead
et al.,10 noted that smaller margins created by the
MIP were of concern, as volumes were not
covered in all ten phases, thus signifying both a
need for larger case size and for visual confirmation
to check coverage of the entire breathing cycle.
It has been illustrated that positron emission
tomography (PET) has improved the staging
and treatment of NSCLC patients.15 Recently,
Callahan et al.16 demonstrated how 4D-PET-
MIP utilises the existing MIP technology and
applies it to PET scans for the same purposes as
used in CT. It was found that 4D-PET enabled
more accurate positioning of target volumes in
the scans of nine patients. The edges of the
volumes were more defined, as was the overall
position. The use of MIP to delineate the targets
was found to be as accurate as the ten-phase
overlap technique. Importantly, PET scans are
more reliable near soft tissue structures, such as
peripheral tumour placements, as the soft-tissue
contrast is greater than in the CT-MIP techni-
que. These findings were supported by a 2012
study17 which concluded that 3D-PET did not
accurately match 4D-CT-MIP delineations.
Further investigations into the use of 4D-PET-
MIP should be considered.
Overall, MIP proves an efficient method of
delineating early stage target volumes. The
drawbacks relating to dosimetric properties and
accuracy during the latter stages of disease prove
to be significant enough to warrant either the
continued use of ten-phase overlap delineations,
or an alternative method.
FB
Liu et al.18 studied 152 patients of stage 2 and
three NSCLC, in order to assess the 3D motion
of target volumes. About 77% of patients did
not receive surgery before planning and treat-
ment, and 60–70% had lesions located within
the central region. The motion detection in
three dimensions was investigated as the authors
Table 1. Delineation methods within literature
Source Delineation
Stage of
disease Results Notes
Bradley et al. 2006 MIP versus AI standard 1 MIP more reliable than AI Unable to calculate electron densities
Muirhead et al.
2008
MIP versus ten-phase
overlap
1–3 MIP for stage 1 faster than
ten-phase overlap; same
accuracy.
Underestimate stage 2–3 disease
Reitz et al. 2009 MIP versus AI (IMRT) 1–3 MIP superior to AI Requires visual confirmation
De Ruysscher et al.
2012
4D-PET-MIP na 4D-PET-MIP more reliable
than PET/CT is to 4D-CT-MIP
4D-PET ten-phase sum equivalent in
volumes to 4D-PET-MIP
Abbreviations: MIP, maximum intensity projection; AI, average intensity; IMRT, intensity modulated radiation therapy; 4D-PET-MIP, four-
dimensional positron emission tomography maximum intensity projection; 4D-CT-MIP, four-dimensional computed tomography maximum
intensity projection.
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noted sufficient literature stating target volume
motion in the lung is anisotropic, disproving the
use of universal margins. The breathing regula-
rities of the patient, tumour size and location are
directly linked to the degree of motion the
target experiences (Table 2).
Using EOE GTV delineation, FB 4DCT
scans were monitored by Varian’s RPM tech-
nology. The infrared markers on the abdomen
allowed the system to track the breathing cycle
effectively, measuring ten phases across the
cycle. Visual verification was required once the
rigid body deformation technique was applied
to the fusion of the GTV phases. This allowed
for the PTV to accommodate for tumour
motion in each phase. The results showed a
higher frequency of motion in the superior and
inferior directions, and lower lobe lesions
moved most often due to close proximity to
the diaphragm. Additionally the smaller lesions
were proved to move more than larger and
superior lesions; this was linked to the effect of
the diaphragm motion.
The report’s findings were strengthened as it
had the most significant sample size of the
articles reviewed; 152 patients with 166 tumours
made for reliable findings. It also reinforced the
claims made by the authors of the effect and
dependency of target motion according to
anatomical and disease-specific characteristics.
The position and motion of the targets is clearly
relevant to the planning of many lung tumours.
Many of the patients were of stage 3 or 4
NSCLC, whereas stage 1 and 2 are the most
likely to have significant motion. A greater
range of patient types could increase the validity
of the results, to avoid skewing of results from
the latter stages of the disease. Additionally,
results could be separated into early and late
stage disease. Future studies should investigate
planning time, staff numbers and workflow
changes required, as well as cost of technology
and systems. Expected control and survival rates
should also be compared with conventional
methods of lung treatments.
Fritz et al.19 performed a study of single-dose
fractionation of 40 stage 1 NSCLC patients that
aimed to measure the side effects, control rates,
survival rates and overall success associated with
4DCT and single-dose treatments. The authors
found 4DCT to be more accurate than 3DCT
for PTV delineation. Furthermore, accounting
for motion in FB planning scans decreased cost
compared with gated treatments, as no extra
technology is required to be installed in the
treatment area. The planning was performed
through the use of three scans; EOI, EOE and
mid ventilation. The combination of these three
scans allowed for a projection of the extent of
target motion during the breathing cycle.7 A
10–15mm margin was placed on the GTV. The
results included 81% control rate at 3 years, with
overall survival for 2 and 3 years at 66% and
53%, respectively. The cancer specific survival
was 71% and 57% for 2 and 3 years post-
treatment, respectively. The side effects to
patients included a 75% rate of radiation
pneumonitis, with no other significant toxicities
or side effects. The strengths of this report
include a significant patient sample size (n5 40),
with similar type and stage of disease; excellent
Table 2. Free-breathing planning and treatment methods within literature
Source Stage Case size Delineation method Results
Liu et al, 2007 2–4 152 EOE Lesions in lower lobes and early stage disease
prove most mobile
Fritz et al. 2008 1 40 EOE, EOI and mid-
ventilation
81% control rate at 3 years
Li et al. 2011 28 3D versus 4D Reduction in PTV size and normal tissue dose;
increase in planning time; individualised margins
cover PTV more accurately
Starkschall et al.
2009
3 15 EOE and deformable
image registration
4D scans allow for reduction in PTV
Reitz et al. 2009 1–4 5 MIP and AI MIP optimal target delineation method
Abbreviations: EOE, end-of-expiration; EOI, end-of-inspiration; PTV, planning target volume; MIP, maximum intensity projection; AI, average intensity.
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for result comparison. The target volume size
was quite variable, which illustrated the abilities
of the 4DCT and planning system to be applied
to a variation of tumours. Patient follow up was
also extensive and ongoing. The reporting of
this data is critical when using IMRT where
long-term effects are still to be determined. The
use of 4DCT for single-fraction treatment of
stage 1 NSCLC has not been reported else-
where at the time of this review, therefore it is
difficult to draw comparative conclusions.
Li et al.20 performed a study on 28 NSCLC
patients, in an attempt to calculate the positional
and volumetric differences of 3DCT and 4DCT
planning methods. Three PTV’s were created
during the planning, one each for the different
scan type and an additional one to measure the
vector difference. The authors found that 4DCT
planning has the potential to decrease the risk of
target miss during treatment and normal tissue
irradiation, by increasing the accuracy of margins
for the patient. Using an individualised technique
is superior as the motion of the target is accounted
for, rather than a universal margin to encompass
‘possible’ motion.
The patients were grouped depending on the
stage of their disease and location of the lesion.
Varian’s RPM system was used to monitor
breathing cycles of patients, ‘binning’ ten phases
of the scan. The physicians delineated the target
volumes on the base slice of 50%, or end
expiration. The results showed a 25–48%
reduction of PTV size and a 30?8–48?4%
decrease in normal tissue dose using 4DCT.
The planning time for 4DCT was higher than
that of 3DCT methods: 28 ± 15 minutes
compared with 5–10 minutes, for GTV delinea-
tion. The report concluded that individualised
margins are able to cover the majority of 4D
target volumes; however this usually results in
over-irradiating normal tissue. The study noted
that to do this using 4DCT increases the
workload of planning systems and patient
exposure. Irregular breathing patterns of patients
can also negate some of the benefits of 4D
systems and a need for coaching or gated
methods would be required. This can be
problematic for NSCLC patients as the age
and co-morbidities often found in patients
can have significant effects on the breathing
patterns.
The strengths of this paper are the comparable
results over a wide variety of patient stages and
pathologies. The position of the lesions, the
stage of the disease and the multiple PTV
delineations allowed for an extensive collation of
data. The variations of motion in all three
dimensions and the positional differences of
lesions are also important to show the effects of
4DCT planning for the different presentations
of disease.
Starkschall et al.21 measured the differences
between dose distributions and calculations of
3D and 4D CT planning systems for 15 NSCLC
stage three patients. CT was combined with
monitoring devices to form a 4D planning
system, depicting ten phases of respiration.
Deformable image registration was used on
each of the ten phases, overlaying the EOE
CTV volume over the nine other phases, in
order to calculate an average dose distribution
throughout the full motion of the target. The
authors noted only a small increase in actual
planning time, yet a significant increase in dose
calculations, as there were ten datasets for the
4DCT compared with one for 3DCT. 4DCT
PTV delineation resulted in an average reduc-
tion of 1?7% of volume compared with 3DCT.
This illustrates the increased accuracy of the 4D
scans, as there was an additional 1mm margin
added to the 3D scans for uncertainty. The
strengths of this paper include the variability of
target volume size and the use of deformable
registration techniques, rather than rigid body
methods. Rigid body is limited by approxima-
tions of the effect of motion, whereas the
planning technique used in this study is similar
to adaptive planning. The report was limited by
the small case size (n5 15) and the use of 3D
planning techniques in a 4D system. Although
4DCT was used, the custom 4D planning was
effectively a copy of 3D methods transferred
across using 4DCT-delineated volumes. The
differences and limitations of gating methods
compared with the 4DCT plan and the
associated outcomes should be further investi-
gated, as well as the effect of respiratory changes
through treatment and the impact of those on
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the dose distribution results. By performing a
4D plan (i.e., using a 4D planning system) a
more accurate representation of results could be
provided. Control and survival rates would also
be useful.
Reitz et al.2 studied the use of simple IMRT
for the planning of five NSCLC patients,
ranging from stage 1–4 disease. Using FB
4DCT, the aim of the study was to quantify
the feasibility of using five-field IMRT for
NSCLC. The 4DCT scan was performed with
an Anzai belt to monitor respiration during the
scan. Target delineation was performed using
maximum intensity (MIP) or mean intensity
(MI or AI) methods.
The authors note that using EOE or EOI proves
less accurate as it fails to account for ant-post and
left-right deviations. It is unrealistic to perform
delineations on ten phases of a patient’s breathing
cycle, due to time constraints in the clinical setting.
Delineation using MIP proved more accurate and
enabled margin reduction compared with that of
AI plans. The margins for MIP plans were 0?8cm
while AI used a 1?5cm margin.
The strengths of this report include the standard
beam arrangement, dose tolerances and the use of
tables and illustrations to concisely depict the gain
of using MIP delineation over AI. The use of
geometric equivalent uniform dose and TCP
tabled information was beneficial, and proved one
of the only pieces of literature to quantify the
probabilities of the planning outcomes.
The limitations of MIP include total lung
volume representation similar to that of EOE
scans, not indicative of the actual lung volume
during treatment. This provides far less lung
volume during most of the treatment cycle
(during FB). Additionally, electron densities cannot
be gained from the MIP image, therefore using
the AI data was required for both total volume
calculations and accurate dosimetric readings.
Gating and tracking
Gated methods in combination with 4DCT
scans provide more accurate alternatives to
conventional 3DCRT planning of NSCLC.
Commonly, a FB 4DCT is used to visualise
the full extent of motion across the breathing
cycle, and to use the most stable region of this
cycle for treatment purposes. Treatments are
delivered using either a breath-hold technique
or FB, where the beam-on of the machine
occurs at pre-determined stages of the respira-
tory cycle.5,22 There are two approaches to
gated treatments, where the breathing cycle is
monitored by internal or external means.
Internal gating requires invasive procedures for
patients who are frequently unfit for such
procedures. External gating can be performed
using detection devices on the abdomen,
spirometers and tracing methods.22 Over 90%
of lung patients can use external systems to
achieve gating, compared with a significantly
lower proportion for internal.8 Table 3 sum-
marises the studies relating to gated techniques.
The use of IMRT-gated treatments for
NSCLC can increase treatment times by as
much as 10 minutes.8 This is due to the beam-
on time representing only 20% of the respiratory
cycle, at the most stable point, usually end-
expiration.23 Calculation and planning can be
15 times longer than the 3DCRTand non-gated
approaches. With increased time, there is a risk
the reduced patient comfort can cause move-
ment. It is possible that cell-repair within the
target may be possible when treatments such as
Table 3. Gated planning and treatment methods within literature
Source Stage Case size Delineation method Results
Underberg et al.
2005
1 31 Isotropic
margins1 ITV
30% PTV reduction for 38%; 50%
reduction for 15%.
van der Voort van
Zyp et al. 2009
1–2 70 na 2-year survival at 96% and 78%;
T-1 disease higher survival rates
Abbreviations: ITV, internal target volume; PTV, planning target volume.
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stereotactic can reach 3 hours for a single
treatment, with an average of 100 minutes. This
raises questions as to the validity of such gated
treatments if the time taken to accurately
position, image and treat according to the
breathing cycle can have a negative effect on
the patient’s quality of life.8
Underberg et al.22 investigated the use of
gated 4DCT planning and treatment for 31
stage 1 NSCLC patients. The aim of the study
was to investigate the benefits of using isotropic
margins and devising a method of future patient
selection. A FB 4DCT scan was performed,
using the Varian RPM device as a means to bin
ten phases of the respiratory cycle. The extent of
motion was observed from the maximum
displacements on the 3D datasets. The ITVs
included all phases of delineated GTV, therefore
accounting for all motion. Isotropic margins
were added to all three ITV’s (10mm, 3mm,
gating with 3mm) to form variable PTVs for
comparison. Eight to 12 non-coplanar beams
were used for the dosimetry process; three separate
fractionation schedules were used to view possible
benefits for hypo-fractionated treatments. The
report concluded that gating offered a 30%
reduction of PTVs for 38% of targets and 50%
in 15% of targets. The conclusions of this article
were strengthened by an appropriate sample size
and the patient selection methods. The reduction
of margins illustrated by the normal tissue dose
regions was effective.
It would be interesting to determine the
impact of the technology on patient quality of
life measures, such as side effects, control rates
and survival rates as well as related costs, ease of
use, staff and workflow requirements of RPM as
well as impact on workload. The use of isotropic
over individualised margins should be investi-
gated further as literature has shown the latter to
be more accurate.
A 2009 study investigated the use of SBRT
using repeat scans and real-time tracking
devices.3 Using a breath-hold technique for
the scanning of patients, repeat scans were used
to confirm positioning of the markers inserted
into the patient. Out of 70 patients with T-1
or T-2 stage NSCLC, two groups were formed:
59 received 60Gy while the remainder received
45Gy over three fractions. The control rate after
2 years was 96% and 78% accordingly, with overall
survival at 62% and cause specific survival at 85%.
Grade 3 toxicity was only experienced in 10% of
patients. It was noted that the control rates were
higher for those with T-1 disease, due to lower
local recurrence risk and smaller target volumes.
The paper highlighted the quality of life results,
which has been overlooked in other literature.
Control rates at 2 years proved high and in line
with similar studies noted in the literature.
CONCLUSION
This review demonstrated that passive techniques
are effective for planning NSCLC treatments. It
has been shown that 4DCT out-performs 3DCT
when accounting for organ motion during
planning, leading to margin reductions and a
more accurate and individualised delineation
process. Various methods of PTV definition have
been identified, with stage-specific recommenda-
tions formed. Briefly, the literature supported
SBRT and IMRT for early and late stage disease
treatment, respectively.
The use of MIP delineation is insufficient for
latter stage disease. This effect could be more
pronounced when irregular breathing patterns
are prominent, where deviations from planning
position can be as high as 8mm. To reduce these
irregularities abdominal compression and
breath-coaching could improve accuracy. Over-
laying MIP-ITV on each scan and adjusting to
ensure coverage allows a quick delineation
process, without the drawback of volume
underestimation. This is slower than MIP as a
sole modality, but quicker than the ten-phase
delineation approach. Daily imaging such as
cone-beam computed tomography matching
should be performed before treatment, espe-
cially in the use of IMRT or SBRT for more
precise positioning. It would be interesting to
see evaluation of more 4D-PET delineation
techniques in future studies to determine the
optimal technique for PTV delineation.
The review highlighted several limitations of
the evidence base and future studies would
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benefit from more standardised measures in
order to increase the fluidity of comparison
between papers. Some remaining questions
concern differences in planning time between
4D and 3D, comparison of gating and FB
efficacy and comparison of delineation times.
The cost of the technologies used, in-house
programs, and the education for staff and
patients required to work effectively within the
department should also be established. Quality
of life data at 5 years needs to be reported for
such work to illustrate the true benefits of
techniques.
Separating early stage and late stage disease
could avoid skewing of data within reports. The
discussion of dose tolerances, planning time
between technologies, costs of systems and
overall departmental efficiency would highlight
feasibility of techniques.
Currently, 3DCRT has reached its limit in the
effectiveness of treating NSCLC. New technolo-
gies such as IMRT are more commonly used in
departments to improve the quality of treatment.
Although gating and SBRT have shown improve-
ments for early stage disease, it is more likely that
FB IMRT will be implemented in departments
due to low cost and minimal workload changes
required. FB IMRTusing a MIP-visual confirma-
tion delineation technique allows for a superior
NSCLC treatment than 3DCRT.
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